Status:
UNKNOWN
Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
Lead Sponsor:
Beijing Children's Hospital
Collaborating Sponsors:
Capital Institute of Pediatrics, China
The First Affiliated Hospital of Anhui Medical University
Conditions:
2019-nCoV
Eligibility:
All Genders
1-18 years
Brief Summary
The study is designed to clarify the clinical characteristics, risk factors and long-term prognosis of children with 2019-nCoV infection in China.
Detailed Description
As of February 10th, 2020, more than 40,000 human have been confirmed infected with a novel coronavirus (2019-nCoV) in China, with at least 800 reported deaths. Additional cases have been confirmed in...
Eligibility Criteria
Inclusion
- For the 2019-nCoV infection group
- Diagnosed with 2019-nCoV infection (with direct laboratory evidence).
- Respiratory or blood samples tested positive for novel coronavirus nucleic acid with RT-PCR.
- Gene sequencing of respiratory or blood samples show highly homologous with known novel coronaviruses.
Exclusion
- Subjects will be excluded if the children or their parents disagree to conduct this study.
- For the control group
- Inclusion Criteria:
- Diagnosed with pneumonia, and excepted of novel coronavirus infection.
- The hospitalization time is the same as that of novel coronavirus pneumonia.
Key Trial Info
Start Date :
February 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04270383
Start Date
February 15 2020
End Date
December 31 2020
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Children's Hospital,
Beijing, China